NCT04299620Active, not recruiting
Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy
Micro-Ultrasound to Whole Mount Image Correlation for Detection and Localization of Prostate Cancer
Source: ClinicalTrials.gov · Last updated 6 Oct 2023
Brief summary (registry, in English)
This trial studies the ability of micro-ultrasound to detect and characterize prostate cancer tumors in patients undergoing radical prostatectomy (removal of the entire prostate and some of the tissue around it). Usually multiparametric magnetic resonance imaging is used for the detection and targeted therapy of prostate cancer, but its accuracy remains imperfect. Micro-ultrasound may be superior as it provides real-time tumor visualization which may simplify and improve prostate cancer targeted therapy. This may also reduce the need for and substantial costs of radical prostatectomy.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 86 (actual)
- First submitted
- 19 Feb 2020
- Start date
- 21 Oct 2020
- Primary completion date
- 14 Jun 2022
- Lead sponsor
- Jonsson Comprehensive Cancer Center
- Diseases
- Prostate cancer
- NCT number
- NCT04299620
What you commit to
- Study type: Interventional
- Participants enrolled: 86
- From 21 Oct 2020 to the primary completion date, 14 Jun 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior radiation or focal treatment for prostate cancer
- Prostate biopsy \< 4 weeks prior to surgery
Other
- Maximum posterior-to-anterior prostate dimension greater than 6 cm
- Inability to have a transrectal ultrasound scan
Who the study is looking for
- Standard-of-care mpMRI within the past 12 months
- Biopsy-proven prostate cancer, Gleason grade \>= 3+3
- Maximum posterior-to-anterior prostate dimension of =\< 6 cm
- Scheduled to receive standard-of-care radical prostatectomy
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UCLA / Jonsson Comprehensive Cancer Center Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.